Coloplast A/S (CLPBF)
CLPBF Stock Price Chart
Explore Coloplast A/S interactive price chart. Choose custom timeframes to analyze CLPBF price movements and trends.
CLPBF Company Profile
Discover essential business fundamentals and corporate details for Coloplast A/S (CLPBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
9 Aug 2000
Employees
16.74K
Website
https://www.coloplast.comCEO
Anders Lonning-Skovgaard
Description
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
CLPBF Financial Timeline
Browse a chronological timeline of Coloplast A/S corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 2 Feb 2026
Upcoming earnings on 4 Nov 2025
Revenue estimate is $7.09B.
Earnings released on 19 Aug 2025
EPS came in at $0.56 falling short of the estimated $0.83 by -32.25%, while revenue for the quarter reached $1.10B , missing expectations by -84.39%.
Earnings released on 6 May 2025
EPS came in at $4.34 falling short of the estimated $4.48 by -3.13%, while revenue for the quarter reached $1.02B , missing expectations by -85.87%.
Dividend declared on 6 May 2025
A dividend of $0.76 per share was announced, adjusted to $0.76. The dividend was paid on 12 May 2025.
Earnings released on 4 Feb 2025
EPS came in at $4.89 surpassing the estimated $0.89 by +449.44%, while revenue for the quarter reached $972.40M , missing expectations by -5.29%.
Dividend declared on 9 Dec 2024
A dividend of $2.41 per share was announced, adjusted to $2.41. The dividend was paid on 10 Dec 2024.
Earnings released on 5 Nov 2024
EPS came in at $5.84 falling short of the estimated $5.97 by -2.18%, while revenue for the quarter reached $1.02B , beating expectations by +1.59%.
Earnings released on 20 Aug 2024
EPS came in at $5.66 falling short of the estimated $5.82 by -2.75%, while revenue for the quarter reached $991.37M , missing expectations by -1.61%.
Earnings released on 7 May 2024
EPS came in at $5.57 falling short of the estimated $5.83 by -4.46%, while revenue for the quarter reached $945.75M , missing expectations by -5.34%.
Dividend declared on 7 May 2024
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 15 May 2024.
Earnings released on 9 Feb 2024
EPS came in at $5.39 falling short of the estimated $5.50 by -2.00%, while revenue for the quarter reached $974.84M , missing expectations by -0.43%.
Dividend declared on 8 Dec 2023
A dividend of $2.31 per share was announced, adjusted to $2.32. The dividend was paid on 12 Dec 2023.
Earnings released on 9 Nov 2023
EPS came in at $5.47 falling short of the estimated $6.08 by -10.03%, while revenue for the quarter reached $878.49M , missing expectations by -3.10%.
Earnings released on 17 Aug 2023
EPS came in at $5.98 surpassing the estimated $5.88 by +1.70%, while revenue for the quarter reached $892.33M , missing expectations by -1.16%.
Earnings released on 11 May 2023
EPS came in at $5.44 falling short of the estimated $6.02 by -9.63%, while revenue for the quarter reached $883.62M , beating expectations by +0.23%.
Dividend declared on 11 May 2023
A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 17 May 2023.
Earnings released on 3 Feb 2023
EPS came in at $5.31 falling short of the estimated $5.80 by -8.45%, while revenue for the quarter reached $881.79M , beating expectations by +1.21%.
Dividend declared on 8 Nov 2022
A dividend of $2.11 per share was announced, adjusted to $2.12. The dividend was paid on 6 Dec 2022.
Earnings released on 7 Nov 2022
EPS came in at $5.79 falling short of the estimated $6.08 by -4.77%, while revenue for the quarter reached $794.09M , missing expectations by -0.57%.
Earnings released on 17 Aug 2022
EPS came in at $6.06 surpassing the estimated $5.82 by +4.12%, while revenue for the quarter reached $821.27M , beating expectations by +1.80%.
Earnings released on 5 May 2022
EPS came in at $4.60 falling short of the estimated $5.80 by -20.69%, while revenue for the quarter reached $818.28M , beating expectations by +0.67%.
Dividend declared on 5 May 2022
A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 11 May 2022.
Earnings released on 25 Jan 2022
EPS came in at $5.66 surpassing the estimated $0.88 by +541.72%, while revenue for the quarter reached $787.81M , beating expectations by +1.34%.
Dividend declared on 3 Dec 2021
A dividend of $2.12 per share was announced, adjusted to $2.13. The dividend was paid on 7 Dec 2021.
Earnings released on 1 Nov 2021
EPS came in at $6.12 falling short of the estimated $6.40 by -4.38%, while revenue for the quarter reached $795.70M , missing expectations by -1.44%.
Earnings released on 18 Aug 2021
EPS came in at $5.88 surpassing the estimated $5.66 by +3.89%, while revenue for the quarter reached $770.75M .
Earnings released on 6 May 2021
EPS came in at $5.30 falling short of the estimated $5.36 by -1.12%, while revenue for the quarter reached $750.91M .
Dividend declared on 6 May 2021
A dividend of $0.82 per share was announced, adjusted to $0.82. The dividend was paid on 12 May 2021.
Earnings released on 2 Feb 2021
EPS came in at $5.33 falling short of the estimated $5.45 by -2.20%, while revenue for the quarter reached $777.98M .
Dividend declared on 4 Nov 2020
A dividend of $2.12 per share was announced, adjusted to $2.12. The dividend was paid on 8 Dec 2020.
Earnings released on 3 Nov 2020
EPS came in at $4.88 falling short of the estimated $5.02 by -2.79%, while revenue for the quarter reached $723.37M .
CLPBF Stock Performance
Access detailed CLPBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.